Abstract
Urinary catheters are one of the most commonly utilized medical devices worldwide. They are used in virtually every healthcare setting and contribute to improvements in patient care. While urinary catheters provide invaluable aid to patients, they are not without complications, the most notable being catheter-associated urinary tract infections (CAUTI). Once a urinary catheter is in place, pathogens may migrate to the bladder one of two ways, through the catheter lumen or extraluminally in the periurethral space. In vitro methods are useful tools for predicting clinical efficacy only if they accurately model the most important factors contributing to a clinical infection. Although in vitro methods can’t replace in vivo scenarios, outcomes may be improved as experiments approximate relevant criteria including the biofilm phenotype, time, media type, materials similarities and environment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
https://www.grandviewresearch.com/industry-analysis/urinary-catheters-market. Accessed June 19, 2018.
- 2.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm. Accessed June 19, 2018.
- 3.
https://www.innov-research.com/product/normal-human-urine?c=1 Accessed June 29, 2018.
References
Control, C.f.D., Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-Associated Urinary Tract Infection [UTI] and Other Urinary System Infection [USI] Events. 2018(Device-associated Module-UTI).
Lo, E., et al. (2014). Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infection Control & Hospital Epidemiology, 35(Suppl 2), S32–S47.
Weiner, L. M., et al. (2016). Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infection Control and Hospital Epidemiology, 37(11), 1288–1301.
Marzo, A., et al. (2018). An engineering approach towards a more discrete and efficient urinary drainage system. Proceedings of the Institution of Mechanical Engineers. Part H, 954411918790286.
Foley, F. E. B. (1937). A hemostatic bag catheter. The Journal of Urology, 38(1), 134–139.
Feneley, R. C., Hopley, I. B., & Wells, P. N. (2015). Urinary catheters: History, current status, adverse events and research agenda. Journal of Medical Engineering & Technology, 39(8), 459–470.
Hanafy, H. M., Saad, S. M., & Al-Ghorab, M. M. (1974). Ancient Egyptian medicine: Contribution to urology. Urology, 4(1), 114–120.
Miller, A., et al. (1958). Postoperative infection in urology. Lancet, 2(7047), 608–612.
Gillespie, W. A., et al. (1960). The diagnosis, epidemiology and control of urinary infection in urology and gynaecology. Journal of Clinical Pathology, 13, 187–194.
Garibaldi, R. A., et al. (1974). Factors predisposing to bacteriuria during indwelling urethral catheterization. The New England Journal of Medicine, 291(5), 215–219.
Garibaldi, R. A., et al. (1980). Meatal colonization and catheter-associated bacteriuria. The New England Journal of Medicine, 303(6), 316–318.
Costerton, J. W., Geesey, G. G., & Cheng, K. J. (1978). How bacteria stick. Scientific American, 238(1), 86–95.
Daifuku, R., & Stamm, W. E. (1986). Bacterial adherence to bladder uroepithelial cells in catheter-associated urinary tract infection. The New England Journal of Medicine, 314(19), 1208–1213.
Nickel, J. C., Gristina, A. G., & Costerton, J. W. (1985). Electron microscopic study of an infected Foley catheter. Canadian Journal of Surgery, 28(1), 50–51, 54.
Costerton, J. W., et al. (1987). Bacterial biofilms in nature and disease. Annual Review of Microbiology, 41, 435–464.
Donlan, R. M., & Issue, S. (2001). Biofilms and device-associated infections. Emerging Infectious Diseases, 7(2), 277–281.
Stoodley, P., et al. (2011). Orthopaedic biofilm infections. Current Orthopaedic Practice, 22(6), 558–563.
Busscher, H. J., et al. (2010). Biofilm formation on dental restorative and implant materials. Journal of Dental Research, 89(7), 657–665.
Hu, H., et al. (2016). Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plastic and Reconstructive Surgery, 137(6), 1659–1669.
Meslemani, D., Yaremchuk, K., & Rontal, M. (2010). Presence of biofilm on adult tracheostomy tubes. Ear, Nose, & Throat Journal, 89(10), 496–504.
Food and Drug Administration, U. (1997). Guidance for the content of premarket notifications for conventional and antimicrobial Foley catheters.
Malpiedi, P. J. (2011). National and state healthcare-associated infection standardized infection ratio report.
Peasah, S. K., et al. (2013). Medicare non-payment of hospital-acquired infections: Infection rates three years post implementation. Medicare & Medicaid Research Review, 3(3).
Saint, S., et al. (2016). A program to prevent catheter-associated urinary tract infection in acute care. The New England Journal of Medicine, 374(22), 2111–2119.
Services, U.D.o.H.a.H. (2013). National action plan to prevent health care-associated infections: Road map to elimination, Executive Summary. p. 1–19.
Hooton, T. M., & Clinical, p. (2012). Uncomplicated urinary tract infection. The New England Journal of Medicine, 366(11), 1028–1037.
Ingersoll, M. A., & Albert, M. L. (2013). From infection to immunotherapy: Host immune responses to bacteria at the bladder mucosa. Mucosal Immunology, 6(6), 1041–1053.
Parsons, C. L., et al. (1990). Bladder surface glycosaminoglycans: An epithelial permeability barrier. The Journal of Urology, 143(1), 139–142.
Carlsson, S., et al. (2001). Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide, 5(6), 580–586.
Raffi, H. S., et al. (2005). Tamm-Horsfall protein acts as a general host-defense factor against bacterial cystitis. American Journal of Nephrology, 25(6), 570–578.
Hannan, T. J., et al. (2012). Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiology Reviews, 36(3), 616–648.
Arinzon, Z., et al. (2012). Clinical presentation of urinary tract infection (UTI) differs with aging in women. Archives of Gerontology and Geriatrics, 55(1), 145–147.
de Lastours, V., & Foxman, B. (2014). Urinary tract infection in diabetes: Epidemiologic considerations. Current Infectious Disease Reports, 16(1), 389.
Lichtenberger, P., & Hooton, T. M. (2008). Complicated urinary tract infections. Current Infectious Disease Reports, 10(6), 499–504.
Levison, M. E., & Kaye, D. (2013). Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens. Current Infectious Disease Reports, 15(2), 109–115.
Chenoweth, C. E., & Saint, S. (2011). Urinary tract infections. Infectious Disease Clinics of North America, 25(1), 103–115.
O’May, G. A., et al. (2009). Complicated urinary tract infections due to catheters., 3, 123–165.
Haley, R. W., et al. (1981). Nosocomial infections in U.S. hospitals, 1975-1976: Estimated frequency by selected characteristics of patients. The American Journal of Medicine, 70(4), 947–959.
Maki, D. G., & Tambyah, P. A. (2001). Engineering out the risk for infection with urinary catheters. Emerging Infectious Diseases, 7(2), 342–347.
Jacobsen, S. M., et al. (2008). Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clinical Microbiology Reviews, 21(1), 26–59.
Stamm, W. E. (1991). Catheter associated urinary tract infections: Epidemiology, pathogenesis, and prevention. The American Journal of Medicine, 91(3B), 65S–71S.
Tambyah, P. A., Halvorson, K. T., & Maki, D. G. (1999). A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clinic Proceedings, 74(2), 131–136.
Saint, S., & Chenoweth, C. E. (2003). Biofilms and catheter-associated urinary tract infections. Infectious Disease Clinics of North America, 17(2), 411–432.
Nickel, J., Grant, S., & Costerton, J. (1985). Catheter-associated bacterium: An experimental study. Urology, 26(4), 369–375.
Warren, J. W. (2001). Catheter-associated urinary tract infections. International Journal of Antimicrobial Agents, 17(4), 299–303.
Barford, J. M., et al. (2008). A model of catheter-associated urinary tract infection inittiated by bacterial contamination of the catheter tip. BJU International, 102(1), 67–74.
Hidron, A. I., et al. (2008). NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control and Hospital Epidemiology, 29(11), 996–1011.
Mulvey, M. A. (2002). Adhesion and entry of uropathogenic Escherichia coli. Cellular Microbiology, 4(5), 257–271.
Struve, C., Bojer, M., & Krogfelt, K. A. (2008). Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence. Infection and Immunity, 76(9), 4055–4065.
Stahlhut, S. G., et al. (2012). Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. FEMS Immunology and Medical Microbiology, 65(2), 350–359.
Fox-Moon, S.M. and M.E. Shirtliff, Urinary tract infections caused by Proteus mirabilis. 2015: p. 1389–1400.
Flores-Mireles, A. L., et al. (2015). Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nature Reviews. Microbiology, 13(5), 269–284.
Nickel, J. C., et al. (1994). Bacterial biofilms: Influence on the pathogenesis, diagnosis and treatment of urinary tract infections. The Journal of Antimicrobial Chemotherapy, 33(Suppl A), 31–41.
Ipe, D. S., Horton, E., & Ulett, G. C. (2016). The basics of bacteriuria: Strategies of microbes for persistence in urine. Frontiers in Cellular and Infection Microbiology, 6, 14.
Justice, S. S., et al. (2008). Morphological plasticity as a bacterial survival strategy. Nature Reviews. Microbiology, 6(2), 162–168.
Stewart, P. S. (1996). Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrobial Agents and Chemotherapy, 40(11), 2517–2522.
Hoyle, B. D., Alcantara, J., & Costerton, J. W. (1992). Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrobial Agents and Chemotherapy, 36(9), 2054–2056.
Mobley, H. L., Island, M. D., & Hausinger, R. P. (1995). Molecular biology of microbial ureases. Microbiological Reviews, 59(3), 451–480.
Stickler, D., et al. (1993). Proteus mirabilis biofilms and the encrustation of urethral catheters. Urological Research, 21(6), 407–411.
Lee, C. R., et al. (2013). Strategies to minimize antibiotic resistance. International Journal of Environmental Research and Public Health, 10(9), 4274–4305.
Raad, I. (1995). Antibiotics and prevention of microbial colonization of catheters. Antimicrobial Agents and Chemotherapy, 39(11), 2397–2400.
Fu, W., et al. (2010). Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrobial Agents and Chemotherapy, 54(1), 397–404.
Gloag, E. S., et al. (2016). Micro-patterned surfaces that exploit stigmergy to inhibit biofilm expansion. Frontiers in Microbiology, 7, 2157.
Gabriel, M. M., et al. (1996). In vitro evaluation of the efficacy of a silver-coated catheter. Current Microbiology, 33(1), 1–5.
Bologna, R. A., et al. (1999). Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: A multicenter study. Urology, 54(6), 982–987.
Karchmer, T. B., et al. (2000). A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Archives of Internal Medicine, 160(21), 3294–3298.
Srinivasan, A., et al. (2006). A prospective trial of a novel, silicone-based, silver-coated Foley catheter for the prevention of nosocomial urinary tract infections. Infection Control and Hospital Epidemiology, 27(1), 38–43.
Pickard, R., et al. (2012). Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: A multicentre randomised controlled trial. The Lancet, 380(9857), 1927–1935.
Medline Industries, I., Silvertouch Foley Catheter: The Standard For Silver. 2009.
Parker, A. E., & Hamilton, M. A. (2011). KSA-SM-10- Assessing Resemblance, Repeatability, and Reproducibility for quantitative methods. Bozeman, MT: C.f.B.E.a.M.S. University.
Shrout, J. D., et al. (2006). The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Molecular Microbiology, 62(5), 1264–1277.
Palmer, K. L., Aye, L. M., & Whiteley, M. (2007). Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. Journal of Bacteriology, 189(22), 8079–8087.
Cotter, P. D., & Hill, C. (2003). Surviving the acid test: responses of gram-positive bacteria to low pH. Microbiology and Molecular Biology Reviews, 67(3), 429–453, table of contents.
Shepard, B. D., & Gilmore, M. S. (2002). Differential expression of virulence-related genes in Enterococcus faecalis in response to biological cues in serum and urine. Infection and Immunity, 70(8), 4344–4352.
Dalhoff, A., Stubbings, W., & Schubert, S. (2011). Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine. Antimicrobial Agents and Chemotherapy, 55(4), 1814–1818.
Barr, D. B., et al. (2005). Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environmental Health Perspectives, 113(2), 192–200.
Torffvit, O., & Agardh, C. D. (1993). Tubular secretion of Tamm-Horsfall protein is decreased in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Nephron, 65(2), 227–231.
Bouatra, S., et al. (2013). The human urine metabolome. PLoS One, 8(9), e73076.
Nowatzki, P. J., et al. (2012). Salicylic acid-releasing polyurethane acrylate polymers as anti-biofilm urological catheter coatings. Acta Biomaterialia, 8(5), 1869–1880.
Wang, J., et al. (2017). Burden of healthcare-associated infections in China: Results of the 2015 point prevalence survey in dong Guan City. The Journal of Hospital Infection, 96(2), 132–138.
Zarb, P., et al. (2012). The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveillance, 17(46).
Hollenbeak, C. S., & Schilling, A. L. (2018). The attributable cost of catheter-associated urinary tract infections in the United States: A systematic review. American Journal of Infection Control, 46(7), 751–757.
Darouiche, R. O. (1997). In vitro efficacy of antimicrobial-coated bladder catheters in inhibiting bacterial migration along catheter surface. Concise Communications. The Journal of Infectious Diseases, 176, 1109–1112.
Gaonkar, T. A., et al. (2003). Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model. Infection Control and Hospital Epidemiology, 24(7), 506–513.
Sherertz, R. J., Forman, D. M., & Solomon, D. D. (1989). Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrobial Agents and Chemotherapy, 33(8), 1174–1178.
Darouiche, R. O., et al. (2008). Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens. The Journal of Antimicrobial Chemotherapy, 61(3), 651–657.
Gomes, L. C., et al. (2015). Escherichia coli adhesion, biofilm development and antibiotic susceptibility on biomedical materials. Journal of Biomedical Materials Research. Part A, 103(4), 1414–1423.
Minuth, J. N., Musher, D. M., & Thorsteinsson, S. B. (1976). Inhibition of the antibacterial activity of gentamicin by urine. The Journal of Infectious Diseases, 133(1), 14–21.
Dave, R. N., Joshi, H. M., & Venugopalan, V. P. (2011). Novel biocatalytic polymer-based antimicrobial coatings as potential ureteral biomaterial: Preparation and in vitro performance evaluation. Antimicrobial Agents and Chemotherapy, 55(2), 845–853.
Hachem, R., et al. (2009). Novel antiseptic urinary catheters for prevention of urinary tract infections: Correlation of in vivo and in vitro test results. Antimicrobial Agents and Chemotherapy, 53(12), 5145–5149.
Roe, D., et al. (2008). Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. The Journal of Antimicrobial Chemotherapy, 61(4), 869–876.
Nickel, J. C., Downey, J., & Costerton, J. W. (1992). Movement of pseudomonas aeruginosa along catheter surfaces. A mechanism in pathogenesis of catheter-associated infection. Urology, 39(1), 93–98.
Dohnt, K., et al. (2011). An in vitro urinary tract catheter system to investigate biofilm development in catheter-associated urinary tract infections. Journal of Microbiological Methods, 87(3), 302–308.
Stickler, D. J., Morris, N. S., & Winters, C. (1999). Simple physical model to study formation and physiology of biofilms on urethral catheters. Methods in Enzymology, 310, 494–501.
Tenke, P., et al. (2004). Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. International Journal of Antimicrobial Agents, 23 Suppl 1, S67–S74.
Chua, R. Y. R., et al. (2017). An in vitro urinary catheterization model that approximates clinical conditions for evaluation of innovations to prevent catheter associated urinary tract infections. The Journal of Hospital Infection, 97, 66.
Morris, N. S., Stickler, D. J., & Winters, C. (1997). Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? British Journal of Urology, 80(1), 58–63.
Curtin, J. J., & Donlan, R. M. (2006). Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy, 50(4), 1268–1275.
Lehman, S. M., & Donlan, R. M. (2015). Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model. Antimicrobial Agents and Chemotherapy, 59(2), 1127–1137.
Roberts, A. E., et al. (2015). The limitations of in vitro experimentation in understanding biofilms and chronic infection. Journal of Molecular Biology, 427(23), 3646–3661.
Purevdorj, B., Costerton, J. W., & Stoodley, P. (2002). Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Applied and Environmental Microbiology, 68(9), 4457–4464.
Heydorn, A., et al. (2000). Experimental reproducibility in flow-chamber biofilms. Microbiology, 146(Pt 10), 2409–2415.
Tolker-Nielsen, T., & Sternberg, C. (2011). Growing and analyzing biofilms in flow chambers. Current Protocols in Microbiology. Chapter 1: p. Unit 1B 2.
Nickel, J. C., et al. (1985). Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro. European Journal of Clinical Microbiology, 4(2), 213–218.
Maeyama, R., et al. (2005). Novel bactericidal surface: Catechin-loaded surface-erodible polymer prevents biofilm formation. Journal of Biomedical Materials Research. Part A, 75(1), 146–155.
McCoy, W. F., et al. (1981). Observations of fouling biofilm formation. Canadian Journal of Microbiology, 27(9), 910–917.
Turnbull, L., & Whitchurch, C. B. (2014). Motility assay: Twitching motility. Methods in Molecular Biology, 1149, 73–86.
Irwin, N. J., McCoy, C. P., & Carson, L. (2013). Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown Proteus mirabilis to the quinolone antimicrobials. Journal of Applied Microbiology, 115(2), 382–389.
Ceri, H., et al. (1999). The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. Journal of Clinical Microbiology, 37(6), 1771–1776.
Meije, Y., et al. (2014). Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection. The Journal of Infection, 68(6), 548–552.
Stickler, D., & Hughes, G. (1999). Ability of Proteus mirabilis to swarm over urethral catheters. European Journal of Clinical Microbiology & Infectious Diseases, 18(3), 206–208.
Sabbuba, N. (2002). The migration of Proteus Mirabilis and other urinary tract pathogens over Foley catheters. BJU International, 89, 55–60.
Reddy, S. T., et al. (2011). Micropatterned surfaces for reducing the risk of catheter-associated urinary tract infection: An in vitro study on the effect of sharklet micropatterned surfaces to inhibit bacterial colonization and migration of uropathogenic Escherichia coli. Journal of Endourology, 25(9), 1547–1552.
Burns, J. R., & Finlayson, B. (1980). A proposal for a standard reference artificial urine in in vitro urolithiasis experiments. Investigative Urology, 18(2), 167–169.
Brooks, T. (1997). A simple artificial urine for the growth of urinary pathogens. Letters in Applied Microbiology, 24, 203–206.
Chutipongtanate, S., & Thongboonkerd, V. (2010). Systematic comparisons of artificial urine formulas for in vitro cellular study. Analytical Biochemistry, 402(1), 110–112.
Grases, F., & Llobera, A. (1998). Experimental model to study sedimentary kidney stones. Micron, 29(2–3), 105–111.
Christmas, K. G., et al. (2002). Aggregation and dispersion characteristics of calcium oxalate monohydrate: Effect of urinary species. Journal of Colloid and Interface Science, 256(1), 168–174.
Acknowledgments
Darla M. Goeres, Ph.D., holds an Innovation in Regulatory Science Award from BWF.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Summers, J., Goeres, D.M. (2019). Catheter-Associated Urinary Tract Infections: Development of a Test Method for Assessing the Efficacy of Antimicrobial Technologies/Products. In: Williams, D. (eds) Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors. Springer, Cham. https://doi.org/10.1007/978-3-030-30667-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-30667-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30666-3
Online ISBN: 978-3-030-30667-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)